www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Haemophilus influenzae

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Vignettes

[Schuchat A, Rosenstein Messonnier N.  From Pandemic Suspect to Postvaccine Era: The Haemophilus influenzae Story. Clin Infect Dis 2007:44;817-819].

Review Article:  Efflux Pumps as a Mechanism of Antimicrobial Resistance. 2008
Broides A, et al. Acute Otitis Media Caused by Moraxella catarrhalis: Epidemiologic and Clinical Characteristics. Clin Infect Dis. 2009 Dec 1;49:1641-7.

Gram stain, 2008

 

Tables and Figures

Table 1: Breakpoints Used to Determine Susceptible, Intermediate, and Resistant Categories for H. influenzae Based on PK/PD, BSAC, and CLSI Interpretative Breakpoints.

Table 2: Susceptibility of Worldwide Isolates of H. influenzae (n=8,523) to 23 Antimicrobials and MIC50s and MIC90sa

Table  3: Some Reported Drug Concentrations in Body Compartments Following Therapeutic Doses of Antibiotics (ug/ml). 

Table 4: Recommended Drug Dosages for Meningitis [Download PDF]

Table 5: Dosages of Antibiotics Used in H. Influenzae Pneumonia and Otitis Media  [Download PDF]

 

Authors

Bradford D. Gessner, Berthe-Marie Njanpop-Lafourcade, Mark A Herbert

Previous Edition (1999 and 2002): Mark A Herbert and Richard E. Moxon

 

 

Smart Search

Guided PubMed Search on the Hit Page

We recommend this option for therapeutic recommendations

Haemophilus influenzae

Select a topic and click onto Submit below:
EPIDEMIOLOGY MICROBIOLOGY CLINICAL MANIFESTATIONS  LAB  DIAGNOSIS PATHOGENESIS
SUSCEPTIBILITY
      In Vitro and In Vivo (Animal) Susceptibility | Synergistic Interactions in vitro
ANTIMICROBIAL THERAPY

     Antimicrobial Agent(s) of Choice | Alternative Therapy  | Combination Therapy | Dose |

     Route of Administration | Duration of Therapy | Endpoints for Monitoring Therapy

ADJUNCTIVE THERAPY
     Non-antimicrobial Therapy
PREVENTION
     General Preventive Measures | Hospital Infection Control Measures | Prophylaxis
VACCINES

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]